Molecular and diffusion features for identification of clinically significant prostate cancer in PI-RADS 3 lesions.
Ajami T, Han S, Porto JG, Kimbel I, Szczotka Z, Guerard T, VanderVeer-Harris N, Ledesma BR, Acosta PC, Kryvenko ON, Parekh DJ, Stoyanova R, Reis IM, Punnen S.
Ajami T, et al. Among authors: porto jg.
Urol Oncol. 2024 Nov;42(11):370.e9-370.e14. doi: 10.1016/j.urolonc.2024.05.025. Epub 2024 Jul 8.
Urol Oncol. 2024.
PMID: 38971674